Michael Boeckh, MD PhD
Professor
Internal Medicine
Fred Hutchinson Cancer Center
Seattle, WA, United States
Disclosure(s): Allovir: Advisor/Consultant (); Amazon: Grant/Research Support (); Ansun Biopharma: Grant/Research Support (); EvrysBio: Advisor/Consultant (); Gates Ventures: Grant/Research Support (); Gilead Sciences: Advisor/Consultant (), Grant/Research Support (); GlaxoSmithKline: Advisor/Consultant (), Grant/Research Support (); Helocyte: Advisor/Consultant (); Janssen: Advisor/Consultant (), Grant/Research Support (); Kyorin Pharmaceuticals: Advisor/Consultant (); Merck: Advisor/Consultant (), Grant/Research Support (); Moderna: Advisor/Consultant (), Grant/Research Support (); Regeneron: Grant/Research Support (); ReViral: Advisor/Consultant (); Symbio: Advisor/Consultant (); Takeda: Grant/Research Support (); Vir Biotechnology: Advisor/Consultant (), Grant/Research Support ()
Michail Lionakis, MD, ScD
Chief, Fungal Pathogenesis Section, Laboratory of Clinical Immunology & Microbiology
National Institute of Allergy and Infectious Diseases (NIAID)/National Institutes of Health (NIH)
Bethesda, MD, United States
Disclosure(s): No financial relationships to disclose
Minh-Hong Nguyen, MD (she/her/hers)
Professor of Medicine
University of Pittsburgh
Pittsburgh, PA, United States
Disclosure(s): QPX: Grant/Research Support ()
John Rex, MD
Chief Medical Officer
F2G, Limited
WELLESLEY HILLS, MA, United States
Disclosure(s): Advent Life Sciences: Operating Partner (), Ownership Interest (); AMR Action Fund: Advisor/Consultant (); AstraZeneca: Stocks/Bonds (); Basilea Pharmaceutica: Advisor/Consultant (); Bugworks Research, Inc.: Advisor/Consultant (); F2G, Limited: Employee (), Stocks/Bonds (); Forge Therapeutics: Advisor/Consultant (); GlaxoSmithKline: Advisor/Consultant (); Pfizer Pharmaceuticals: Honoraria (); Sumitovant: Advisor/Consultant ()
Nkechi Azie, MD MBA FIDSA
VP, Clinical Development
SCYNEXIS, Inc.
Jersey City, NJ, United States
Disclosure(s): SCYNEXIS, Inc.: employee (), Stocks/Bonds ()
Stephen Brand, Ph.D
Chief Development Officer
Mycovia Pharmaceuticals, Inc
Durham, NC, United States
Disclosure(s): Mycovia Pharmaceuticals: I am an employee of Mycovia Pharmaceuticals. Mycovia Pharmaceuticals funded the Phase 3 clinical studies presented (Ongoing)
Theresa Matkovits, PhD (she/her/hers)
Chief Development Officer
Matinas BioPharma
Bedminster, New Jersey, United States
Disclosure(s): Matinas BioPharma: Employee ()
Taylor Sandison, MD, MPH (he/him/his)
Chief Medical Officer
Cidara Therapeutics
San Diego, CA, United States
Disclosure(s): Cidara Therapeutics: Employee (Ongoing), Stocks/Bonds (Ongoing)
Ubaldo Martin, MD (he/him/his)
VP Clinical Development
Pulmocide
Penn Valley, PA, United States
Disclosure(s): Pulmocide Ltd.: Honoraria (Ongoing), Stocks/Bonds (Ongoing)
No CE credits offered
Speaker: Nkechi Azie, MD MBA FIDSA – SCYNEXIS, Inc.
Speaker: Theresa Matkovits, PhD (she/her/hers) – Matinas BioPharma
Speaker: Emma L. Harvey, MBBS – F2G Ltd
Speaker: Ubaldo J. Martin, MD (he/him/his) – Pulmocide
Speaker: Taylor Sandison, MD, MPH (he/him/his) – Cidara Therapeutics
Speaker: Stephen Brand, Ph.D – Mycovia Pharmaceuticals, Inc